Dyne Therapeutics to Present at February Investor Conferences

Rhea-AI Summary

Dyne Therapeutics, Inc. (Nasdaq: DYN) announced their participation in two investor conferences in February, including the Guggenheim Healthcare Talks and Oppenheimer Healthcare Life Sciences Conference. The company will present a live webcast of each presentation, with a replay available for 90 days.

WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to present at the following investor conferences in February:

• Guggenheim Healthcare Talks | 6^th Annual Biotechnology Conference, fireside chat on Thursday, February 8, 2024 at 11:00 a.m. ET in New York
  

• Oppenheimer 34^th Annual Healthcare Life Sciences Conference, virtual fireside chat on Wednesday, February 14, 2024 at 2:40 p.m. ET
  

A live webcast of each presentation will be available in the Investors & Media section of Dyne’s website at https://investors.dyne-tx.com/news-and-events/events-and-presentations and a replay will be accessible for 90 days.

About Dyne Therapeutics

Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.

Contact:

Amy Reilly
areilly@dyne-tx.com
857-341-1203

FAQ

What is the ticker symbol for Dyne Therapeutics, Inc.?

The ticker symbol for Dyne Therapeutics, Inc. is DYN.

When is Dyne Therapeutics, Inc. scheduled to present at the Guggenheim Healthcare Talks?

Dyne Therapeutics, Inc. is scheduled to present at the Guggenheim Healthcare Talks on Thursday, February 8, 2024 at 11:00 a.m. ET.

Where can the live webcast of Dyne Therapeutics, Inc.'s presentation be accessed?

The live webcast of Dyne Therapeutics, Inc.'s presentation can be accessed in the Investors & Media section of Dyne’s website at https://investors.dyne-tx.com/news-and-events/events-and-presentations.

How long will the replay of Dyne Therapeutics, Inc.'s presentation be accessible?

The replay of Dyne Therapeutics, Inc.'s presentation will be accessible for 90 days.